KORU Medical Systems, Inc.

$ 3.90 0.52 %

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.

CEO: Linda Tharby - https://www.korumedical.com

Price objectif

$7.5 92.31 %

Recommandation

Buy

DCF

$ -10.67

Loading data...

KRMD vs S&P500

Loading data...

No data available.

Quick ratio

1.82

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-78.00

may indicate that the company is undervalued or has poor growth prospects.

EPS

-0.05

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-13.61 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-12.78 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

6.15

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.20

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.00

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
9.35 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.99 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.12 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.